We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
424 result(s) found, displaying 301 to 310
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BENLYSTA belimumab 400 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BENLYSTA belimumab 120 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MENVEO meningococcal (Groups A, C, W-135 and Y) oligosaccharide CRM197 conjugate vaccine.
-
Australian public assessment report (AusPar)Australian public assessment report for Human papillomavirus vaccine types 16 and 18 (recombinant AS04 adjuvanted)
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Purified antigen fractions of inactivated split virion A/Indonesia/05/2005 (H5N1), AS03 adjuvanted
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Umeclidinium bromide
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Umeclidinium bromide and Vilanterol trifenatate
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd